118 results
SC 13E3/A
EX-99
PRDS
Pardes Biosciences Inc
31 Aug 23
Going private transaction (amended)
8:53am
in the CVR Register shall be the valid obligations of the Company and shall entitle the transferee to the same benefits and rights under this Agreement
SC 14D9/A
PRDS
Pardes Biosciences Inc
17 Aug 23
Tender offer solicitation (amended)
5:09pm
and perceived benefits of any product related to the CVR Assets, if approved, relative to existing and future alternative therapies for COVID-19 based upon … of severance payments and benefits by the Company’s executive officers under the Company’s Executive Severance Plan;
With respect to Mses. Henson
SC 14D9
PRDS
Pardes Biosciences Inc
28 Jul 23
Tender offer solicitation
5:04pm
safety data post-approval to ensure continued regulatory approval, (viii) demonstrate the actual and perceived benefits of any product related … Pardes Restricted Share;
The potential receipt of severance payments and benefits by the Company’s executive officers under the Company’s Executive
SC TO-T
EX-99
FS Development Holdings II, LLC
28 Jul 23
Third party tender offer statement
5:01pm
-approval to ensure continued regulatory approval, (viii) demonstrate the actual and perceived benefits of any product related to the CVR Products … their entitlement to benefits under an applicable income tax treaty and the manner of claiming the benefits of such treaty.
In addition, if payments are made
SC TO-T
EX-99
qd53u7p3yetnchl7fzp0
28 Jul 23
Third party tender offer statement
5:01pm
SC TO-C
skfhxu77dutio
17 Jul 23
Information about tender offer
7:58am
SC TO-C
EX-99.1
domnhw y2ce
17 Jul 23
Information about tender offer
7:58am
SC14D9C
EX-99.1
exfvv2
17 Jul 23
Written communication relating to third party tender offer
7:11am
SC14D9C
5isl0twvhrwvd f84y20
17 Jul 23
Written communication relating to third party tender offer
7:11am
8-K
EX-99.1
c9uq4cns2ae
17 Jul 23
Entry into a Material Definitive Agreement
7:06am
8-K
EX-2.1
dom c4xyz3b3
17 Jul 23
Entry into a Material Definitive Agreement
7:06am
8-K
EX-10.1
u2snjii
17 Jul 23
Entry into a Material Definitive Agreement
7:06am
8-K
4rttgnft4k6zhfq1h1f3
17 Jul 23
Entry into a Material Definitive Agreement
7:06am
8-K
EX-10.1
v6qr9cbv
5 Jun 23
Departure of Directors or Certain Officers
4:02pm
8-K
76om0o34tkvyuvqta92z
18 May 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.2
e832drfcnuhe5mzwdzmh
18 May 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
qbn4eq8p 3c
18 May 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-99.1
upnawiwdohi1ym
5 May 23
Pardes Biosciences Reports First Quarter 2023 Financial Results
4:02pm